94769 ⎘
Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms Nitrogen and either oxygen or sulfur atoms
SOLID CRYSTALLINE FORMS OF HELICASE-PRIMASE INHIBITORS AND PROCESS OF PREPARATION THEREOF
#2PLEUROMUTILIN DERIVATIVE WITH THIAZOLE SIDE CHAIN AND PREPARATION AND APPLICATION
#3COMPOSITIONS AND METHODS FOR MAKING AND USING SMALL MOLECULES FOR TUBULIN-TARGETED THERAPY IN THE TREATMENT OF CANCERS AND RELATED CONDITIONS
#4CHROMOBOX PROTEIN INHIBITORS AND USES THEREOF
#5DESIGN, SYNTHESIS AND MECHANISMS OF ANTICANCER ACTIVITY OF NEW ACETYLATED 5-AMINOSALICYLATE-THIAZOLINONE HYBRID DERIVATIVES
#6POLYMORPHS OF PONESIMOD
#7Metabolically Stable HDAC Inhibitors with Trifluoromethylpyruvamide as Metal-Binding Group
#8PROCESS FOR PREPARING (2Z)-2-(PHENYLIMINO)-1,3-THIAZOLIDINE-4-ONE-SULFOXIDE DERIVATIVES IN AN ENANTIOMERICALLY ENRICHED FORM
#9DEUTERATED AMINOTHIAZOLE COMPOUNDS AS ANTIVIRAL COMPOUNDS
#10CRYSTALLINE FORMS OF {2-[3-CYCLOHEXYL-3-(TRANS-4-PROPOXY-CYCLOHEXYL)-UREIDO]-THIAZOL-5-YLSULFANYL}-ACETIC ACID AND USES THEREOF
#11SALTS OR CO-CRYSTALS OF {2-[3-CYCLOHEXYL-3-(TRANS-4-PROPOXY-CYCLOHEXYL)-UREIDO]-THIAZOL-5-YLSULFANYL}-ACETIC ACID AND USES THEREOF
#12SULFOXIDE AND SULFONE GLUCOKINASE ACTIVATORS AND METHODS OF USE THEREOF
#13PROCESS OF PREPARING 2-(PHENYLIMINO)-3-ALKYL-1,3-THIAZOLIDIN-4-ONES
#14Physics-driven discovery of novel small therapeutic compounds for use as a BCL-2 inhibitor
#15WDR5-MYC INHIBITORS
#16SULFONAMIDE INHIBITORS AS CTPS1 INHIBITORS
#17PROCESS OF PREPARING 2-(PHENYLIMINO)-1,3-THIAZOLIDIN-4-ONES
#18Pesticidal compositions and methods
#19Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
#20Crystalline polymorph of Ponesimod
#21Aminothiazole Derivatives Useful As Antiviral Agents
#22FARNESOID X RECEPTOR AGONISTS AND USES THEREOF
#23Pharmaceutical composition for ANO1 antagonist with anticancer activity
#24Chromobox protein inhibitors and uses thereof
#25Substituted 2-imino-1,3-thiazolidin-4-ones as N-arachidonoylethanolamine cellular uptake inhibitors
#26Thiazole derivative and applications thereof
#27Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
#28POLYMERIZABLE COMPOSITION COMPRISING AN OXIME SULFONATE AS THERMAL CURING AGENT
#29Substituted 2-imino-1,3-thiazolidin-4-ones as N-arachidonoylethanolamine cellular uptake inhibitors
#30Aminothiazole derivatives useful as antiviral agents
#314-oxo-4,5-dihydrothiazole derivative, preparation method and use thereof
#32Compositions comprising metformin and a glucokinase activator
#33Sulfonylaminobenzamide compounds as anthelmintics
#34ROR gamma (RORγ) modulators
#35Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto
#36Inhibitors of the Notch transcriptional activation complex and methods for use of the same
#37MOLECULES HAVING CERTAIN PESTICIDAL UTILITIES, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES RELATED THERETO
#38Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
#39Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator
#40Thiazolidinone compounds and use thereof
#41Sulfonylaminobenzamide compounds as anthelmintics
#42Substituted 2-imino-1,3-thiazolidin-4-ones as N-arachidonoylethanolamine cellular uptake inhibitors
#43DERIVATIVES OF N-(ARYLAMINO) SULFONAMIDES AS INHIBITORS OF MEK
#44Asparagine endopeptidase (AEP) inhibitors for managing cancer and compositions related thereto
#45N-arylamidine-substituted trifluoroethyl sulfide derivatives as acaricides and insecticides
#46NITRIFICATION INHIBITORS
#47Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
#48Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator
#49Aryl sulfide derivatives and aryl sulfoxide derivatives as acaricides and insecticides
#50Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto
#51Polymerizable composition comprising an oxime sulfonate as thermal curing agent
#52Apoptosis-inducing agent for the treatment of cancer and immune and autoimmune diseases
#53(4E)-4-(4-substituted benzylideneamino)-2,3-dihydro-3-substituted-2-thioxothiazole-5-carbonitriles as A2AR antagonist and process for preparation thereof
#54Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto
#55Process for the preparation of (2Z,5Z)-5-(3-chloro-4-(()-2,3-dihydroxypropdxy)benzylidene)-2-(propylimino)-3-(-tolyl)thiazolidin-4-one and intermediate used in said process
#56Inhibition of MCL-1 and/or BFL-1/A1
#57Compounds and compositions for use in augmentation of glucose
#58Positive allosteric modulators for melanocortin receptors
#59Broad spectrum benzothiophene-nitrothiazolide and other antimicrobials
#60Compounds for modulating integrin CD11B/CD18
#61Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto
#62Molecules having certain pesticidal utilities, and intermediates, compositions, and processes related thereto
#63Compounds that modulate intracellular calcium
#64Synthetic lethal targeting of glucose transport
#65Modulators of ATP-binding cassette transporters
#66Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria
#67Necroptosis inhibitors and methods of use therefor
#68ASYMMETRIC PROCESS FOR MAKING SUBSTITUTED 2-AMINO-THIAZOLONES
#69Thiazolidin-4-one-derivatives
#70Polymerizable composition comprising an oxime sulfonate as thermal curing agent
#71COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM
#72HAPTEN CONJUGATES FOR TARGET DETECTION
#73Substituted 3-thiazoloamino-propionic acid derivatives and their use as pharmaceuticals
#74Compounds for modulating integrin CD11b/CD18
#75PROPHYLACTIC OR THERAPEUTIC AGENT FOR CANCER
#76Process for the preparation of 2-imino-thiazolidin-4-one derivatives
#77Thiazolidin-4-one derivatives
#78Acetamide derivatives as glucokinase activators, their process and medicinal applications
#79PROPHYLACTIC OR THERAPEUTIC AGENT FOR CANCER
#80Alkylsulfinyl-substituted thiazolide compounds
#81Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
#82Derivatives of N-(arylamino)sulfonamides as inhibitors of MEK
#83Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
#84Broad spectrum benzothiophene-nitrothiazolide and other antimicrobials
#85Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator
#86Modulators of ATP-binding cassette transporters
#87ARYL CARBONYL DERIVATIVES AS THERAPEUTIC AGENTS
#88Method of treating cancer by inhibition of protein kinase-like endoplasmic reticulum protein kinase
#89BENZAMIDE GLUCOKINASE ACTIVATORS
#90Process for the preparation of 2-imino-thiazolidin-4-one derivatives
#91Crystalline forms of (R)-5-[3-chloro-4-(2,3-dihydroxy-propoxy)-benz[Z]ylidene]-2-([Z]-propylimino)-3-0-tolyl-thiazolidin-4-one
#92Thiazolidinone derivative
#93Asymmetric process for making substituted 2-amino-thiazolones
#94Process for making substituted 2-amino-thiazolones
#95HETEROAROMATIC GLUCOKINASE ACTIVATORS
#96INHIBITORS OF 11-BETA-HYDROXY STEROID DEHYDROGENASE TYPE 1
#975-substituted-2-imino-thiazolidinone compounds and their use as inhibitors of bacterial infection
#98NEW PROCESS FOR THE PREPARATION OF 2-IMINO-THIAZOLIDIN-4-ONE DERIVATIVES
#99Acetamide derivatives as glucokinase activators, their process and medicinal application
#100Substituted pyrazine compounds
#101Modulation of pathogenicity
#102Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
#103Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
#104Compounds for modulating integrin CD11b/CD18
#105New Acetyl Coenzyme A Carboxylase (ACC) Inhibitors And Uses In Treatments Of Obesity And Diabetes Mellitus - 087
#106Thiazolidin 4-one derivatives
#107ARYLMETHYLIDENE HETEROCYCLES AS NOVEL ANALGESICS
#108Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs
#109Benzamide glucokinase activators
#110Non-Peptidic Inhibitors of AKAP/PKA Interaction
#111Dicycloalkyl urea glucokinase activators
#112Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
#113Thiazolidin-4-one derivatives
#114Arylsulfones and uses related thereto
#115Neurotrophin production/secretion promoting agent
#116Modulators of ATP-binding cassette transporters
#117Thiazolidin-4-one derivatives
#118Thrombopoietin activity modulating compounds and methods
#119Heteroaromatic glucokinase activators
#120Heterocyclic compounds as pharmaceutical agents
#121Aryl carbonyl derivatives as therapeutic agents
#122Aryl carbonyl derivatives as therapeutic agents
#123THROMBOPOIETIN ACTIVITY MODULATING COMPOUNDS AND METHODS
#124Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
#125Materials and methods to potentiate cancer treatment
#126Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
#127Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
#128FBPase inhibitors for diabetes
#129Inhibitors of 11-Beta-Hydroxy Steroid Dehydrogenase Type 1
#130CXCR1 AND CXCR2 CHEMOKINE ANTAGONISTS
#131Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
#132CALCIUM CHANNEL ANTAGONISTS
#133Calcium channel antagonists
#134Integrin-binding small molecules
#135Diaminopropionic acid derivatives
#136Catalyzed process of making C-5-substituted heterocyclic inhibitors of 11β-hydroxy steroid dehydrogenase type 1
#137Thiazolidin-4-one derivatives
#138Biarylurea derivatives
#139Iminothiazolidinone derivatives as SFRP-1 antagonists
#140Aryl carbonyl derivatives as therapeutic agents
#141Aminobenzophenone compounds
#142Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
#143Thrombopoietin activity modulating compounds and methods
#144Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
#145Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors
#146Modulators of ATP-binding cassette transporters
#147Thiazolyl inhibitors of Tec family tyrosine kinases
#148CXCR1 and CXCR2 chemokine antagonists
#149Arylsulfones and uses related thereto
#150Serine protease inhibitors
#151New compounds
#152Selective inhibitors of the urokinase plasminogen activator
#153Diaminopropionic acid derivatives
#1544-thiazolidinone derivatives as EGFR inhibitors for anti-tumor activity
#155Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof